Essay on A Brief Note On The Lawsuit And Settlement
* the lawsuit (and settlement) basics - what the lawsuit is about etc.
The Pradaxa lawsuit concerns the serious side effects associated with the use of Pradaxa (dabigatran).
The side effects include rectal, brain and gastrointestinal bleeding. The other side effects of Pradaxa include GERD, gastrointestinal cancer and abdominal pain and discomfort. Those who were affected by the drug filed a lawsuit against the drug manufacturer, Boehringer Ingelheim Pharmaceuticals.
over 4,000 people have already received compensation from the Boehringer Ingelheim, a German based drug maker as part of the MDL settlement.
Reports have shown that thousands of people who have used the drug have suffered various side effects, while several hundreds have died as a result. the first deaths from the use of Pradaxa were reported in 2011, when over 540 patients died from using Pradaxa and thousands more reported suffering serious side effects. many of the Pradaxa lawsuits were filed in the federal court, while many others were consolidated into a single multidistrict litigation (MDL) in the US District Court based in Southern District Illinois. the case was filed under MDL No.2385, in Re: Pradaxa Product Liability Litigation. Boehringer Ingelheim agreed to a settlement of 650 million to the affected 4,000 people in the case, even though U.S. District Court Judge David Herndon had on the verge of presiding over a number of trials relating to the use of Pradaxa. Judge David R,…